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Elucidating the role of genes in the ontogenesis of the 
cardiovascular system is a task that involves many fields of 
inquiry. Recent dramatic advances in the molecular biology 
of transcription and its variations and the prospects for 
sequencing the entire human genome must not induce 
complacency; the major task of determining how a one- 
dimensional code specifies a three-dimensional structure 
demands an understanding of biologic systems considerably 
beyond the current level. The study of pathologic cardio- 
vascular ontogeny is equally in need of new insight and 
fresh approaches. Although all clinicians might agree that 
genes are important contributors to both the etiology and 
the pathogenesis of congenital heart defects, with the ex- 
ception of a few Mendelian conditions, this knowledge 
cannot be put to practice beyond crude statements of 
empirically determined probabilities. In this review, we 
selectively examine studies that are addressing what we 
perceive as provocative issues and suggest some areas, such 
as chaos theory, in which new ideas might be found. 
(J Am Co11 Cardiol1989;13:1458-68) 
Congenital anomalies of the structure of the heart have been 
described since the time of Leonardo da Vinci and Mor- 
gagni, but it was Maude Abbott (1,2) early in this century 
who first investigated systematically and rigorously (from 
1,000 personal cases) the pathology of such 
anomalies. Helen Taussig (3) extended this en- 
quiry to the bedside and showed that much 
pathology could be deduced by clinical exami- 
nation and the simple tests then available, the 
electrocardiogram and chest radiograph. Most 
clinicians, however, dismissed specific diagnosis 
because they believed that cardiac anomalies 
“ . . . were hopeless finalities in which the func- 
tion of the physician was limited to matters of 
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majority of congenital heart defects, and many pathologists 
and clinicians might concur, no one has yet developed 
successful ways to render this belief practical. All who deal 
with patients give counsel as best they can about current and 
future affected relatives; but, except for the 
occasional Mendelian disorder, advice is based 
on an all-purpose empiric recurrence risk esti- 
mate of 3 to 5%. This approach has scarcely 
changed in 3 decades, an embarrassing contrast 
with developments in cellular, developmental 
and molecular biology. 
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general advice and prognosis” (4). Angiocardiography, car- 
diac catheterization and, more importantly, cardiac surgery 
rapidly and profoundly changed this sense of futility. 
Although the diagnosis and management of congenital 
heart disease have made impressive progress, understanding 
etiology and pathogenesis has not. This observation is par- 
ticularly true for the role of the genome in congenital cardiac 
anomalies, whose study has never engendered any saltatory 
advances akin to the first repair of a patent ductus arteriosus 
or the first palliation of tetrology of Fallot. Indeed, although 
most embryologists believe that genes are important in the 
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Accurate genetic counseling requires not only 
precision in diagnosis but knowledge of cause. 
Effective management of disease requires not 
only understanding of natural history and therapeutics but 
knowledge of pathogenesis. In most instances of cardiac 
anomalies, etiology and pathogenesis are unknown; discov- 
ering them is the focus of this article. Our goals are to review 
in brief the methods used to address these issues and the 
reasons that, at best, they have led to partial answers, to 
urge the study of pathophysiologic mechanisms in develop- 
mental systems subject to evolutionary constraint and to 
This article is part of a series of articles celebrating the 
40th anniversary of the American College of Cardiology. 
The series attempts to set the stage for the future by 
describing current state of the art management of selected 
major cardiovascular problems and the basic knowledge 
that will provide directions for advances in diagnosis and 
therapy. 
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identify directions of research likely to promote clinical 
effectiveness. We limit ourselves to structural anomalies of 
the heart evident during embryogenesis and, if compatible 
with survival, evident at birth. Excluded are disorders of 
electrophysiology, some of which are clearly genetic, and 
the many age-dependent heritable disorders that are not 
congenital, for example, the autosomal dominant hypertro- 
phic and dilated cardiomyopathies, mitral valve prolapse and 
the Marfan syndrome. 
Preliminary Considerations 
We well understand the risk of compressing the massive 
information bearing on the genetics of congenital heart 
disease. But, because our chief purpose is to place what is 
known in the perspective of where future investigation might 
be directed, we state our beliefs with brief support. 
First, the embryology of the heart is unquestionably under 
genetic control. For example, some disorders of ontogeny 
segregate in families as Mendelian traits. About 11% of 
autosomal and X-linked disorders that are compatible with 
survival into adulthood affect the cardiovascular system; the 
figure is 17% for those Mendelian disorders lethal in the 
neonatal period (5). Moreover, most phenotypes caused by 
aneuploidy, including common ones such as the Down and 
Turner syndromes. lead to major cardiovascular malforma- 
tions. 
Second, how genes exert their eflects on organogenesis is 
not ut all clear from simple inspection of the clinical pheno- 
type. In some Mendelian disorders, the cardiovascular man- 
ifestations of the phenotype tend to breed true, as in the 
common atrium of the Ellis-van Creveld syndrome. In the 
Noonan syndrome, the malformation is quite diverse in 
detail (septal hypertrophy, pulmonary valve stenosis, pul- 
monary artery stenosis, aortic valve stenosis), but perhaps 
somewhat more unified in general (all defects are obstruc- 
tive). In lesions less clearly Mendelian, in which multiple 
genes and environmental factors are usually incriminated, 
relatives of probands, although at increased risk of cardio- 
vascular malformations, often have anatomically disparate 
lesions. If what is encoded by the genome is the specific 
anatomic structure, these empiric facts are difficult to un- 
derstand. On the other hand, ready interpretation may prove 
possible if the genome encodes mechanisms of development. 
For instance, we surmise that genes control both the 
amounts of factors that govern growth and development of a 
particular organ as well as whether they are active or 
inactive. A defect in one developmental gene might have 
pleiotropic effects not in one organ only but in distant parts 
of the body as well (6). 
Third, a major area of uncertainty relevant to both normal 
and defective ontogeny is how genetically encoded chemical 
messages are transformed into processes with spatiul orien- 
tation, handedness and highly organized timing. That such 
requirements are reliably met is unequivocal, but details and 
the way that specialized nuances, such as asymmetries either 
of structure (for example, the rotation of the heart) or of 
function (for example, the cerebral hemispheres) are accom- 
modated, remain obscure. Selection pressures require that 
these developmental demands be met with high reliability: 
one result is the precise conservation of the d-cardiac loop 
across diverse taxonomic classes. Reliability would presum- 
ably be favored by simple processes rather than complex 
ones, by properties that are intrinsic (such as the geometric 
consequences of physical relations) rather than arbitrary (as 
the genetic codes) and by redundancy rather than uniqueness. 
We thus begin with strong presumptions in favor of robust 
processes with rich properties, rather than complicated, frag- 
ile and narrowly specific devices. 
Fourth. the heart has a vital role at even’ stage of 
evolution of higher organisms. Mutation is rare and not at 
once relevant unless it alters the overt phenotype. In con- 
trast, reproduction, by which mutation is integrated and 
perpetuated in the human gene pool, is common and effi- 
cient. As a result, cardiac defects are heavily penalized in 
the genetic sense that selection impedes reproduction. For 
our purposes here the most important implication is that 
ontogenic mechanisms need not be complex. 
Fifth, ontogeny is regulated to some extent by homeosta- 
sis or “feedback” (7). Common experience. such as navi- 
gating across large distances, shows that provision for re- 
ducing cumulative effects of small initial errors and their 
propagation vastly reduces the demands of accuracy of the 
preliminary course. Hence, there is powerful selective value 
to feedback control in developmental mechanisms, just as 
there is for physiologic ones (8,9). However, feedback 
control is necessarily unbiased and uny such process with a 
mean eflect qf zero would not ordinarily be detected by 
classic quantitative genetics. 
Fundamental Approaches to Congenital 
Heart Disease 
Several academic approaches have helped our under- 
standing of the nature and origin of congenital heart disease: 
high resolution investigations of molecular and cellular dys- 
function, embryology and teratology, careful inspection of 
clinical phenotypes, formal genetic analysis of empiric data 
and theoretic modeling. They are most usefully seen as 
complements rather than as rivals (Fig. 1). The genetics of 
cardiac anomalies cannot be fully understood until the 
diverse demands of every approach are satisfied. Another, 
generally tacit, principle is that congenital heart disease will 
not be grasped until “normal” cardiac development is un- 
derstood, and vice versa. 
Each approach must accommodate certain demands. The 
functioning heart of a progenitor must be perpetuated by 
reliable mechanisms in the offspring. These mechanisms 
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must prescribe, at a minimum, a means of encoding in 
deoxyribonucleic acid (DNA) both the chemical constituents 
of the cardiovascular system and the ways the chemical 
messages are to be translated into the phenomena of embry- 
ology-how a one-dimensional genetic instruction specifies a 
three-dimensional structure. It is not enough that the mes- 
sage instructs cells to form diverse tissues: a teratoma does 
that. There must also exist methods of ensuring both topo- 
logic and geometric organization of these tissues to form the 
heart itself and the spatial orientation of the heart within the 
body. When the mechanism goes awry, it is not enough to 
document that the same cardiac lesion recurs in the relatives 
of probands; one must also explain why there are both a 
higher risk of disparate cardiovascular lesions in the rela- 
tives of probands and structural changes at distant sites, 
especially the craniofacies and the hand. Moreover, a reli- 
able ontogenic mechanism alone is insufficient; the phyloge- 
netic path by which the mechanism evolved must be de- 
duced and satisfy evolutionary dynamics and conservatism. 
The latter is exemplified by the use of the same parts and 
mechanisms repeatedly. 
Figure 1. Epistemologic linkages in normal and 
pathologic development. A, In normal develop- 
ment, the genome is the primary component of the 
system that directs development; the macroenvi- 
ronment (for example, the mother) and the micro- 
environment (for example, local oxygen tension) as 
well as stochastic (for example, chance and chaos) 
factors influence the system but not to the point of 
disruption. The arrows indicate the directions of 
information flow. Alongside the components of this 
schema (italics) are the fields of study especially 
devoted to them. B, In pathologic development, 
the schema is identical to that of A, but the 
components reflect subsets of the former and the 
fields of study have been modified. Medical genet- 
ics subsumes cytogenetics, immunogenetics and 
biochemical genetics. 
Finally, it is not enough to know in exquisite detail the 
biochemistry of development, because genetic (and hence 
evolutionary) selection operates not on these basic mecha- 
nisms but on the remote, coarse-grained clinical phenotype, 
which governs such crass matters as survival, reproduction 
and death. The demands made by the various constituents of 
Figure 1 may even be in open conflict. The physiologist and 
embryologist perhaps suppose that mechanisms do not have 
to be simple, and indeed there is much biochemistry to 
support grand multiplicity. On the other hand, the evolutionist 
will seek mechanisms that are simple, robust, pleiotropic and 
adaptable. We call attention to these clashes, which sober the 
triumphant accounts of success in many individual, narrow 
enquires. 
Perspectives on Formal Studies 
Population Studies 
Epidemiologists typically appeal to the notion that things 
that are independent in cause will have independent effects, 
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and conversely. This notion is a kind of minimalist logic: it is 
insensitive, but it is highly secure because the axiom of 
independence can rarely be challenged. In the present con- 
text, this approach has had two areas of application. 
First it has shown that certain types of heart defects occur 
together more often than could be accounted for by chance. 
Thus arises the notion of the syndrome: the tetralogy of 
Fallot or the concurrence of lesions of the hand and the 
heart, as in the Holt-Oram syndrome. Such conjunctions can 
be studied without any family history at all and do not 
necessarily imply the interjection of genetic factors. 
Second, relatives of probands with congenital heart dis- 
ease are themselves at higher risk of congenital heart disease 
than are unselected subjects or their relatives. Many surveys 
of congenital heart disease have been of this kind and have 
established beyond doubt that there is “familial aggrega- 
tion” (10-12). Furthermore, relatives of probands are also at 
added risk of cardiac lesions other than those in the pro- 
bands (11,13.14). These findings alone do not prove a genetic 
cause because relatives tend to share similar habits, diet. 
social status, infections, any of which might be culpable. 
Nevertheless, it is at least suggestive evidence. Few epide- 
miologists go beyond this minimalist logic of independence 
and, with some justification, need to be taken to task for 
their neglect of genetic factors (15-17). The impact of the 
closeness of relation between affected individuals on etiol- 
ogy has been examined to some extent; unfortunately, 
nebulous terms such as “first degree” relatives have too 
often been used. ignoring the fact that sibling-sibling. moth- 
er-son, mother-daughter, father-son and father-daughter are 
all first degree relations but with quite different implications 
under any rational genetic model. There has also been little 
concern with false paternity, birth order (with the impact of 
sensitizing pregnancies) and parental age. matters that a 
geneticist would automatically address. Some recent explor- 
atory studies (12,lS) have dealt with these issues much more 
clearly. 
Gene&+ Studies 
The geneticist generally insists on rather more structure 
than does the epidemiologist. The most important addition is 
detailed study of the pedigree. Epidemiologic minimalism 
would not, for instance, ordinarily distinguish between a 
population in which all subjects were at 10% risk of a defect 
and one in which 10% of the population are at 100% risk. To 
the geneticist, the distinction would be vital. 
Five classic approaches may be mentioned. 
Chromosomal approach. For some 70 years it has been 
known that genetic information is contained in the chromo- 
somes. Even in disorders that are genetically lethal (that is, 
preclude reproduction) or nearly so, such as the Turner and 
Down syndromes. the occurrence of heart defects in the 
phenotype is taken to be evidence of a genetic etiology on 
grounds of karyotype, not of genealogic pattern. 
Mendelian approach. More than a dozen congenital dis- 
orders of cardiac structure show evidence of being caused by 
a defect at a single genetic locus and occur often enough to 
be familiar to most clinicians. A far greater number of 
“private” syndromes, occurring in apparent Mendelian pat- 
tern in one or a few families, have been described; however, 
few meet the most stringent standards of proof. Many 
pseudomendelian disorders are known in animals in which 
extended breeding studies have shown that a trait is due to a 
tight cluster of genes rather than one locus. In humans, such 
deception would show up in an extensive pedigree, as genes 
in a cluster eventually segregate; however. because of a 
trend to smaller families and of reproductive disability, a 
given rare phenotype commonly is not transmitted, or, if it 
is. rapidly dies out and so deprives us of the critical 
evidence. For this reason. Mendelian inheritance is, para- 
doxically. more readily demonstrated for recessive traits, 
such as the Ellis-van Creveld syndrome. than for the more 
conspicuous dominant disorders. 
Galtonian approach. Certain traits are evidently under 
the control of multiple loci, all more or less equally impor- 
tant and with additive effects. Fisher (19) showed that, when 
measurable. such traits tend to follow the Gaussian 
(“normal”) distribution. and the degree of similarity among 
relatives can be adequately expressed-as Galton had ex- 
pressed it 40 years previously-by regression and correla- 
tion coefficients. A thriving field of quantitative genetics has 
resulted. We mention four shortcomings of this model (20). 
First, the “democratic” assumption that the genes are many 
and have comparable impacts on the phenotype. The model 
does not, for instance, account for a phenotype parfly 
determined by a major single locus. Second, to require 
additivity limits the area of applicability. Many well estab- 
lished examples violate this assumption, for example, chem- 
ical interactions subject to the law of mass action. Third, the 
model is not concerned with what the components are and 
hence (especially in view of the “democratic” assumption) 
has no heuristic value; indeed, it is a dead end inquiry. 
Fourth, in the present context, congenital cardiovascular 
defects are not matters of measurable changes but quantal 
phenotypes; that is. the person concerned either exhibits the 
trait or not-there is no intermediate state. (To anticipate, 
we may point out that modern trends in noninvasive high 
resolution phenotyping will shift inquiry toward quantitation 
of structural distortions, such as that which occurs in the 
Ebstein heart, the size of septal defects and subclinical 
manifestations of any malformation.) 
Threshold approach. Although widely used in analysis of 
hypercholesterolemias, blood pressure and allied topics, 
classic Gahon-Fisher analysis has shed little light on cardiac 
malformations. However. a modification derived from the 
work of Pearson (21) is the threshold model. It is based on 
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the idea that a measurable trait may itself exhibit continuous 
variation, but only those values above a threshold lead to 
overt disease. A classic illustration is that blood pressure 
may vary continuously, but there is an abrupt change in the 
clinical picture when at some critical pressure a berry 
aneurysm ruptures. The cardiologist (dealing with the blood 
pressure) and the neurologist (dealing with subarachnoid 
hemorrhage) may see the disorder quite differently. Pearson 
used his threshold model in two distinguishable models: 
where there is a measurable trait underlying the dichotomy 
(the analogue of the blood pressure in the hemorrhage) and, 
somewhat more cautiously, where the measurable trait is 
unidentified and indeed quite conjectural. The principal 
proponents of this threshold model in congenital heart dis- 
ease have been the Noras (22,23) and Sanchez-Cascos (11). 
There has been neither a claim that the hypothetical “mea- 
surable” trait has been identified nor, so far, much attempt 
to find it. But Nora and Nora (23) have found in extensive 
family data that the recurrence rate in relatives corresponds 
to the expected (average) rate predicted from Pearson’s 
method by Edwards’ approximation (24). We stress that 
Edwards predicted the average rate, not the probability of 
being affected; and the Noras (22,23) have been in some 
difficulties in applying their results to the probability of 
recurrence when more than one relative is already affected. 
Nor is this surprising, because the mathematics is laborious 
even with the computer program of Curnow (25) and Smith 
(26). We may add that as it stands, this model sheds no light 
on the increased risk of discordant lesions in relatives. 
Our intent is not to belittle these studies: in genetic 
analysis of such traits they represent the highest level of 
achievement so far, and perhaps nothing more sophisticated 
is practicable. In the last 15 years, no better analysis has 
been put forward. 
Logistic regression approaches. This method of dealing 
with quanta1 characters has achieved some popularity in 
recent years. It has a long history of use in bioassay; and 
generalization of it to deal with cardiovascular traits due to 
multiple measurable causal factors has been elaborated 
(27,28). It is especially valuable in dealing with several 
causal factors, some discrete and some continuous. It is not 
expressly Galtonian in logic except that any measurable trait 
may be seen as the resultant of several additive effects. On 
the other hand, it much more readily accommodates explicit 
Mendelian structure than do other quantitative epidemio- 
logic models, and it has been applied recently to familial 
aggregation of congenital heart disease (12,29). 
Etiology and Pathogenesis 
The approaches so far have been directed to finding the 
causes of congenital cardiac malformations. However, it is 
necessary to make a distinction that to medical readers will 
be obvious but to many nonmedical geneticists may seem 
very subtle. The notion of the cause of a disease comprises 
two features: etiology and pathogenesis. They deal as it were 
with the ingredients and the recipe, respectively. To quote a 
familiar genetic example, the etiology of sickle cell disease is 
perhaps better known than that for any other disease; yet the 
pathogenesis of the sickle cell crisis, or growth retardation, 
or arterial occlusions is still mysterious. Yet it is of these 
crass complications that the patient dies, and that Darwinian 
selection takes its toll, rather than the anomalous biochem- 
istry in the beta chain of hemoglobin. In no sense can the 
genetics of the disorder be said to be understood until all the 
links from mutation to the “bottom line” phenotype have 
been made clear. Structural cardiovascular defects are pre- 
sumably the end point of a disorder in the process by which 
the heart and vessels develop. To deepen our understanding 
of it, we must turn to a study of normal development. 
Embryology 
We consider this vast subject not only in the terms in 
which it has been formulated by most embryologists but also 
in its relation to fields to which it is ordinarily a stranger. 
What are the genetic factors involved in embryology, and are 
the appropriate methods qualitative or quantitative? How far 
are the studies directed to grappling with, not anatomy alone 
or biochemistry alone, but with the explicit operation of the 
mechanism connecting the two? Can the data of experimen- 
tal and descriptive embryology on genesis and pathogenesis 
be cast in terms that can be usefully explored in humans? 
In the century since Born’s pioneering studies (30) on 
human cardiogenesis, much descriptive research has ap- 
peared and been critically reviewed (31-33). Not surpris- 
ingly, controversy persists about aspects of normal human 
cardiac development, and the major impediment of access to 
specimens cannot be totally circumvented by examination of 
animals, even other mammals. Extrapolations to human 
organogenesis from structures observed in other higher 
organisms are hazardous and not supportable solely on the 
basis of striking similarities of macromolecules across spe- 
cies. Species should be expected to differ in how they 
regulate complex processes such as embryogenesis, and 
little variation in control is required to produce major 
alterations in the finished product. As Jacob (34) has put it, 
evolution LG. . is always a matter of tinkering.” 
Morphogenetic processes in embryogenesis. Impressive 
gains in the understanding of the cellular and molecular 
biology of human fetal development in general (35-37) and of 
the human heart specifically (3839) have far outstripped 
more classic embryologic morphology. One widely held 
schema explains embryogenesis by the six morphogenetic 
processes listed in Table 1. Much current basic research 
focuses on the molecular bases for these processes, their 
regulation and their coordination (36,40-42). 
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Table 1. Fundamental Processes of Morphogenesis 
Cell proliferation 
Migration of cells 
Migration of sheets of cells 
Cell death 
Cell differentiation 
Pattern formation 
The Role of Classification 
In clinical medicine as in all other fields, the prime 
requisite for any classification is utility. Inevitably, a variety 
of classifications for the same group of disorders emerges 
and reflects a diversity of interests. For congenital heart 
disease, a clinical classification based on the presence or 
absence of cyanosis, shunts, abnormal pulmonary blood 
flow and so forth has ready application in bedside diagnosis, 
but with no evident or accepted relevance to etiology or 
pathogenesis. This common, if unobstrusive, clash between 
the goal of the clinician to cater to individual needs and that 
of the scientist to seek sound generalities (43) exists in 
medical genetics as well. Classic human genetics appealed to 
the existence of homogeneous classes, so that the findings in 
unrelated families could be generalized. Only thus has it 
been possible to understand concepts like mutation rate, 
paternal age effect and selection. In major ways, modern 
molecular biology has undermined this premise, and for the 
population survey, we find substituted exquisitely detailed 
studies on one family, one individual or perhaps a single cell 
line. 
Classification of congenital malfunctions based on patboge- 
netic mechanisms. It is unclear how best to adapt the bur- 
geoning molecular understanding of normal and abnormal 
development for the epidemiologist, the genetic statistician 
or the clinician interested in malformations of the cardiovas- 
cular system. A key issue is whether the classification of 
cardiovascular malformations is cast in the right terms. 
Utility of the threshold model. beyond simple predictions of 
Table 2. Classification of Congenital Cardiovascular 
Malformations Based on Pathogenetic Mechanism* 
Mechanistic Group 
Mesenchymal tissue migration 
errors 
Intracardiac blood flow defects 
Extracellular matrix abnormalities 
Abnormal cellular death 
Looping and situs abnormalities? 
Abnormal targeted growth: 
Example of Malformation 
Tetralogy of Fallot 
Coarctation of the aorta 
Endocardial cushion defect 
Ebstein anomaly 
L-transposition of the great 
arteries 
Total anomalous pulmonary 
venous return 
*Classification scheme after Clark (44.45): ithese groups are hypothesized 
and not yet substantiated by experiment. 
recurrence risks in populations, has not blossomed because 
it has been used without any attempt to identify the charac- 
teristic on which the threshold was predicated. 
If, as we surmised in the previous section, the real 
importance of genes in congenital heart disease resides in 
perturbations of mechanisms, then both theoretic modeling 
and a search for empiric validation must be based on a 
classification of defects rooted in ontogeny. We find the 
scheme proposed by Clark [(44) and personal communica- 
tion 19891 appealing (Table 2). The first four of his six 
pathogenetic classes are supported by experimental evi- 
dence, mostly in animals. An ongoing, prospective investi- 
gation of congenital heart disease, with reasonable attention 
to both genetics and epidemiology, has utilized this classifi- 
cation to stratify data analysis (12,45,46), with results some- 
what different from other recent work (13,23,47). 
Classification based on embryonic bemodynamics. Table 3 
expands on the class of anomalies due to abnormal embry- 
onic blood flow patterns; some defects are caused by de- 
creased flow in the right heart chambers and others caused 
by decreased flow in the left. The probands in the Baltimore- 
Washington Infant Study (12) were partitioned by this clas- 
sification and the familial prevalence of cardiovascular mal- 
Table 3. Congenital Cardiovascular Defects Associated With Altered Embryonic Hemodynamics 
Percent of 
Timing of Alteration Type of Alteration Resultant Defect Flow Defects* 
Before ventricular septarion Increased left heart flow Perimembranous ventricular septal defect 30.8 
After ventricular septation Decreased left heart flow Hypoplastic left heart, mitral or aortic atresia 10.7 
Aortic valve stenosis 13.5 
Bicuspid aortic valve n.d. 
Patent ductus arteriosus 5.5 
Increased right heart flow Hypoplastic right heart, tricuspid/pulmonary atresia 4.4 
Pulmonary valve stenosis 14.9 
Secundum atria1 septal defect II.0 
Independent of ventricular Abnormal direction of ductus Interruption of the aortic arch, type A and aortic 9.1 
septation arteriosus blood flow coarctation 
*Adapted from ref. 48 on the basis of 363 probands with a congenital cardiovascular malformation classified as due to abnormalities of hemodynamics out 
of a total of 570 cases ascertained. n.d. = not determined. 
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formations was determined by history. In relatives of the 363 
patients with flow lesions (29% of all probands), 37 first 
degree relatives were affected (45,48). Further partitioning 
probands by defect and race and employing regressive 
logistic models produced strong evidence for etiologic het- 
erogeneity in familial aggregation. Relatives of black pro- 
bands with perimembranous ventricular septal defects and 
relatives of white probands with right heart defects were 
both at increased risk of some cardiovascular malformation. 
The data are still insufficient to ask whether the heterogene- 
ity is due solely to race (an imprecise descriptor in genetic 
terms) or to additional genetic factors. For one flow- 
associated defect, hypoplastic left heart, the collaborators in 
this study preformed echocardiography on the first degree 
relatives of probands in 14 families (49), five relatives with 
previously undetected and one with known bicuspid aortic 
valve (another flow-associated defect) were found, a fre- 
quency of 12.5% which was considerably greater than the 
estimated population prevalence of about 1%. Affected 
relatives clustered in families in which probands had no 
extracardiac malformations. 
Prospects for Improved Understanding of the 
Genetics of Congenital Heart Disease 
Little further is to be gained, we believe, by refinements 
of classification or family studies based on coarse, clinical 
phenotypes. The mechanistic system proposed by Clark (44) 
seems useful, at least provisionally, for the immediate future 
in guiding studies of pathogenesis. A system in generalities 
and specifics based on etiology will emerge only when a 
great deal more work is performed, perhaps along the lines 
we suggest in this section. Descriptions of familial occur- 
rences, even novel ones, of cardiovascular anomalies are 
unlikely to prove useful beyond counseling of individual 
families. More bird watching is passe; the ornithologist must 
reign henceforth. 
Classic Genetics 
One should not infer from the foregoing that family 
studies will be unprofitable. At least two applications of 
pedigree analysis need to be capitalized on. 
Linkage analysis. For cardiovascular malformations that 
behave as Mendelian traits, their segregation within a pedi- 
gree can be compared with segregation of cloned DNA 
probes that contain restriction fragment length polymor- 
phisms (RFLPs) (5&53). If a given RFLP tends to occur in 
affected, but not in unaffected, relatives, the DNA probe 
may be close to a gene that causes the malformation. With a 
large enough family and a probe sufficiently close to the true 
mutant locus, the human gene map location of the defect can 
be narrowed considerably. As the human genome becomes 
saturated with anonymous DNA probes, mapping a Mende- 
lian disorder will become trivial. For the next few years, 
yield will be highest when a DNA probe from a gene of 
known function shows total linkage (that is, no recombina- 
tion) with a cardiac phenotype; for the families showing no 
recombination between a candidate gene and the disorder, 
the product of that gene, or one very close to it, is part of the 
cause. This approach has shown the cause of some forms of 
osteogenesis imperfecta to be mutations in either the pro (Y 1 
or pro (Y 2 genes of type I collagen (54,55), and the cause of 
the Stickler syndrome in some families to be the pro (Y 1 gene 
of type II collagen (56). Demonstrating nonlinkage is also 
useful; the cause of the Marfan syndrome is not any of the 
common fibrillar collagens, elastin or the core protein of 
proteoglycan (57,58). 
Reverse genetics. Demonstrating close linkage (that is, 
occasional recombination) with an anonymous DNA probe 
only narrows the map location to a few million base pairs. 
Considerable work remains to “walk” or “jump” along the 
chromosome to identify the gene sequence in which the 
mutation resides and then to determine the product of that 
gene (59). This process, termed “reverse genetics,” has 
demonstrated that, in Duchenne muscular dystrophy, a 
protein called dystrophin is defective (60) and that, in 
chronic granulomatous disease, one of the two polypeptides 
comprising cytochrome b is defective (61). But a great many 
more apparently Mendelian disorders, including familial 
polyposis coli, Huntington disease, myotonic dystrophy and 
cystic fibrosis have been mapped, although their loci remain 
unidentified or even conjectural (53). Several Mendelian 
cardiovascular disorders, especially Marfan syndrome and 
hypertrophic and dilated cardiomyopathies, will likely be 
mapped and their biochemical defects identified or verified 
by reverse genetics. 
These and other technical capabilities for asking and 
answering questions engendered by molecular biology will 
have a major impact on cardiovascular diseases and the 
practice of cardiology. However, two caveats bear mention- 
ing. First, at present, gene mapping and reverse genetics are 
applicable only to those congenital malformations clearly 
caused by mutation at a single locus. The next step will be 
to explain in molecular terms how the presence of one too 
few or too many alleles at a particular locus, as occurs in 
chromosome aneuploidy such as the Down syndrome, pre- 
disposes to cardiac anomalies. The final stages-explaining 
the cause and pathogenesis of the majority of congenital 
heart diseases-is the subject of the latter part of this 
section. 
The second caveat pertains to the highly visible, national 
and international efort to sequence the entire human ge- 
nome. Once this sequence is accomplished, and it surely will 
be in a decade or two, the job of understanding the molecular 
basis of common and multifactorial diseases will not be 
finished-just starting. Indeed, the tasks of deducing how 
the 3 billion-nucleotide linear sequence is organized into 
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genes, what these 50,000 or so genes produce and what 
regulatory elements lie in and around each gene will appear 
trivial (though they are far from it) compared with the task of 
deducing how these genes function in systems. An alphabet 
of 26 letters gives no hint of the richness and complexity of 
the language. Similarly, to a naive observer enquiring about 
the diversity of immunoglobulin specificities, being pre- 
sented with tandem arrays of slightly different nucleotide 
sequences would provide scant clue; only in light of the 
system of combinatorial joining, flexible joining and somatic 
point mutation does the solution emerge. 
Segregation analysis of subclinical phenotypes. Mendelian 
disorders, especially dominant ones, show considerable in- 
trafamilial variability. If some aspect of a mechanism of 
morphogenesis or of a homeostatic system were controlled 
by a single gene, and that gene were mutant in some 
members of a family, the phenotype might vary widely 
among them. If some of these affected relatives had an 
obvious congenital cardiovascular anomaly, others with the 
same mutation might have a subclinical anomaly that could 
remain undetected by insensitive methods of detection such 
as auscultation, electrocardiogram or chest radiograph. 
More sensitive, yet noninvasive, techniques are now avail- 
able for detecting subtle variations in structure; cross- 
sectional echocardiography, Doppler color echocardiog- 
raphy and, especially, nuclear magnetic resonance imaging 
may well detect relatives who have a clinically silent cardio- 
vascular anomaly and, hence, are presumptively heterozy- 
gous for the same mutant gene as their more flagrantly 
affected family members. There will be at least two benefi- 
cial applications. First, with appropriate hypotheses and 
controls, segregation analysis and linkage analysis can be 
improved considerably. Second, pathogenetic mechanisms 
will be unraveled and major gene effects supported if a 
spectrum of ontogenetically related defects is found segre- 
gating in a family (14.48). 
aeration. but the topology is unchanged. In distinction, 
closures of the ductus arteriosus and the foramen ovale 
change the topology of the cardiovascular system. In addi- 
tion, cardiac morphogenesis must deal with geometry; for 
instance, a hypoplastic left heart is topologically intact but 
functionally inadequate. Indeed, because the embryonic 
heart supports the developing embryo as the heart itself is 
developing, its geometry, topology and function are intri- 
cately related. 
Mathematical models of growth. A number of topics in 
pure mathematics-catastrophe theory (63), chaos theory 
(64.65). fractal sets (66-68)-have been cultivated with some 
thought of their biologic implications. Progress has lan- 
guished in part because of their difficulty and chilly abstract- 
ness. Nonetheless, some results demonstrate both how 
worthwhile additional investigations might prove and how 
difficult it is for intuition, examining the empirical facts 
alone, to discern the level of complexity of the causal 
mechanisms. We have found in our own studies in dynamic 
systems as applied to the regulation of growth that a wide 
range of apparently quite different and disparate forms-the 
circle. spiral, dome, membranous sheet, torus and digita- 
tions-may result from a single model with only two arbi- 
trary specifications (69.70). In other words, the notion that 
so complex a task as generating the geometry (as distinct 
from the fine structure) of the heart requires the instructions 
from a very large number of genetic loci may be misleading. 
For instance, a rough approximation to the hand can be 
achieved by five instructions (Fig. 2); and the same five 
instructions specify mechanisms that conceivably account 
for much of the anatomy of the heart. 
Another fresh approach is a stochastic (probabilistic) 
single gene model of mammalian malformations (71). Intro- 
duction of chance in addition to genes and environment has 
also been suggested as a refinement of multifactorial models 
(71). 
Embryologic Modeling 
Changes in topology and geometry. In a recent book, 
Arthur (62) notes that attempts to recast natural selection in 
genetic terms (known as neo-Darwinism) have been feasible 
only because genetics had a well established, general ab- 
stract theory. In stark contrast, such a general and abstract 
theory does not exist for embryology, despite much descrip- 
tive and experimental work and even a few attempts at 
modeling. In the absence of such a theory, entente between 
embryology and neo-Darwinism is unlikely, and serious 
study of the genetics of congenital heart disease is seriously 
impaired. At the same time, it is hard to say what the exact 
form of this theory of morphogenesis would be. It seems 
clear that it must be concerned with topology, that is, those 
properties that are unchanged by bending and stretching. 
For instance, at birth the geometry of the lungs is changed by 
Further detailed descriptive investigation of human car- 
Embryologic Research 
diogenesis will be hampered by ethical and political imped- 
iments to fetal research. Reexamination of fetal specimens 
that were preserved years ago will contribute some insight 
(72.73). Experiments in animals will continue to suggest 
ontogenetic mechanisms that may be generalizable (74) but 
difficult to test in humans. 
Molecular biologic approaches to embryogenesis. We do 
expect, however, major progress in molecular embryology in 
the near future. In particular, intriguing results are emerging 
on the roles of three classes of genes and their products: 
oncogenes (75) and growth factors (7678), cell surface 
molecules such as integrins (79,80) and homeotic genes 
(37.81). Cardiovascular abnormalities, although not neces- 
sarily congenital ones, are well known accompaniments of 
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Figure 2. The adage of a hand generated by a model of a dynamic 
system. In each diagram, the same two paths are involved, gener- 
ating the right two digits and the others, respectively. The lobes are 
unlike adult fingers but resemble their precursors, the primitive buds 
in the limb disk. The grouping of the fingers corresponds to 
innervation. Each group is defined by the path of a dynamic process 
whereby growth is directed by pre-axial and post-axial centers 
(technically called targets). Two variables (measures of the strength 
and proportions of each adjustment) control each path and a fifth 
variable specifies the angle between the branches of the cusp 
(arrow). The tracings show a progressive increase in the lengths of 
the digits toward the middle. Changes of the cusp angle alone 
produce patterns characteristic of the hand deformities seen in the 
polydactylies, Holt-Oram syndrome and various clefting malforma- 
tions (lobster claw and so forth). The paths start from a common 
cusp (arrow). A (normal), The thumb lies at the bottom left, the little 
finger at bottom right. B, The paths start somewhat earlier and a 
deep cleft forms between the third and fourth fingers as in the so 
called “absence” deformities. C, The left path starts late and no 
thumb forms, as in the Holt-Oram syndrome. 
heritable defects of the extracellular matrix, such as the 
mucopolysaccharidoses and the Marfan syndrome. The im- 
portance of connective tissue to the structural stability of 
differentiated tissues is incontrovertable (82-84). Less well 
appreciated, however, is the crucial role of the extracellular 
matrix during embryogenesis and organogenesis (85-87). A 
subtle, genetically specified variation in one macromolecule 
of connective tissue markedly affects not only that molecule 
but also the myriad of other components of the matrix (88). 
These alterations, in turn, can affect any of the fundamental 
processes of embryogenesis (Table 1). If the genetic change 
either was inherited from a parent similarly affected or arose 
in an egg or sperm that underwent a spontaneous mutation, 
then the entire embryo will be affected and widespread 
pleiotropic effects may appear (6). Alternatively, the genetic 
change in connective tissue may arise in a single cell of the 
early embryo and produce somatic mosaicism in which only 
the clonal descendants of the mutant cell will be abnormal. 
The resultant phenotype and its transmission will depend on 
where those mutant cells migrate in the embryo, how widely 
the extracellular matrix they produce encounters nonmutant 
embryonic cells and other factors yet to be identified (89). 
Somatic mutation: etiology of cardiac malformations. So- 
matic mutation is much more common than was thought 
even 5 years ago, and it is quite obviously not limited to 
connective tissue. The phenomenon may prove to be ex- 
tremely important in the etiology of many congenital malfor- 
mations. One special class of somatic mutation is that which 
occurs in a gonad and produces germinal mosaicism. The 
individual who is a germinal mosaic for a mutation that 
causes a dominant phenotype (as many congenital malfor- 
mations may be) will be clinically normal, but all offspring 
will have a risk of being affected in proportion to the number 
of mutant germ cells. This nuance, among others, will 
increasingly complicate genetic counseling in the future. 
Genetic Regulation of Complex Systems 
The molecular biology of gene regulation will hold our 
interest for years to come. It will become clearer that the 
same signal (often a polypeptide such as a hormone receptor 
or a product of a homeotic gene) can induce one gene, 
repress another and render a third sensitive to regulation by 
another signal such as a hormone. We will begin to under- 
stand how environmental factors such as pressure and 
temperature modulate gene expression and, thereby, devel- 
opmental and compensatory alterations of cardiovascular 
structure and function. 
Investigations of the genetic regulation of developmental 
processes other than organogenesis may well shed light on 
congenital malformations. Even a thorough understanding 
of how genes control physiologic homeostasis, such as blood 
glucose levels (9), may generate practical solutions to more 
complex cybernetic systems. 
Fields as diverse as fundamental mathematics, fluid 
dynamics and cellular automata (90,91) may ultimately be 
applicable to understanding congenital cardiovascular de- 
fects. Already the chaos theory is finding wide attention in 
population dynamics; extending its precepts to cellular 
dynamics is not unrealistic. 
Conclusion 
Substantial progress toward understanding how genes are 
involved in etiology and pathogenesis of congenital heart 
disease is likely in the next decade. Indeed, this progress will 
only be part of a much more complete picture of human 
ontogeny. Achieving this progress will involve vastly more 
than molecular biology, although that field will have a 
preeminent technical contribution. The major obstacle will 
be fundamental investigations of highly complex, interactive 
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systems: both the theory and empiric studies are in their 
infancy. 
We end with the optimistic projection that before many 
more years pass, simple reliance on a stock “3% to 5%” 
recurrence risk for anxious parents will prove not only 
inappropriate but inaccurate. The burden on the clinician to 
understand the affected child’s congenital defect, its etiology 
and pathogenesis and the likely contribution of the parents’ 
genes will increase, but the reward in more informed coun- 
seling will be even greater. 
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